Life-style and metformin for the prevention of endometrial pathology in postmenopausal women

Carlo Campagnoli, Chiara Abbà, Simona Ambroggio, Tiziana Brucato, Patrizia Pasanisi

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

In western women, the endometrium is frequently exposed, even after menopause, to the endogenous hormonal stimulation. Such a stimulation increases the risk of pathologic conditions such as endometrial hyperplasia and type I (endometrioid) endometrial adenocarcinoma. Metabolic syndrome, obesity, insulin resistance and type II diabetes promote the endometrial stimulation, and are recognized risk factors for endometrial cancer. Furthermore, chronic hyperinsulinemia linked both to obesity and metabolic syndrome influences endometrial proliferation through direct and indirect actions. Intentional weight loss, calorie restriction and physical activity are associated with a reduced risk of the endometrial pathology. Biological mechanisms include reduction in insulin and sex steroid hormone levels. In addition to life-style modifications, the antidiabetic metformin may be proposed as preventive agent. Metformin reduces the metabolic syndrome, lowers insulin and testosterone levels in postmenopausal women, and it is a potent inhibitor of endometrial cancer cell proliferation.

Original languageEnglish
Pages (from-to)119-124
Number of pages6
JournalGynecological Endocrinology
Volume29
Issue number2
DOIs
Publication statusPublished - Feb 2013

Fingerprint

Metformin
Life Style
Endometrial Neoplasms
Pathology
Obesity
Insulin
Endometrioid Carcinoma
Endometrial Hyperplasia
Hyperinsulinism
Gonadal Steroid Hormones
Menopause
Endometrium
Hypoglycemic Agents
Type 2 Diabetes Mellitus
Insulin Resistance
Testosterone
Weight Loss
Cell Proliferation
Exercise

Keywords

  • Endometrial cancer
  • Endometrial hyperplasia
  • Insulin
  • Metformin
  • Sex hormones

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Obstetrics and Gynaecology

Cite this

Life-style and metformin for the prevention of endometrial pathology in postmenopausal women. / Campagnoli, Carlo; Abbà, Chiara; Ambroggio, Simona; Brucato, Tiziana; Pasanisi, Patrizia.

In: Gynecological Endocrinology, Vol. 29, No. 2, 02.2013, p. 119-124.

Research output: Contribution to journalArticle

Campagnoli, Carlo ; Abbà, Chiara ; Ambroggio, Simona ; Brucato, Tiziana ; Pasanisi, Patrizia. / Life-style and metformin for the prevention of endometrial pathology in postmenopausal women. In: Gynecological Endocrinology. 2013 ; Vol. 29, No. 2. pp. 119-124.
@article{a093a2b9610e41ffb3ed21c3cdf72cd5,
title = "Life-style and metformin for the prevention of endometrial pathology in postmenopausal women",
abstract = "In western women, the endometrium is frequently exposed, even after menopause, to the endogenous hormonal stimulation. Such a stimulation increases the risk of pathologic conditions such as endometrial hyperplasia and type I (endometrioid) endometrial adenocarcinoma. Metabolic syndrome, obesity, insulin resistance and type II diabetes promote the endometrial stimulation, and are recognized risk factors for endometrial cancer. Furthermore, chronic hyperinsulinemia linked both to obesity and metabolic syndrome influences endometrial proliferation through direct and indirect actions. Intentional weight loss, calorie restriction and physical activity are associated with a reduced risk of the endometrial pathology. Biological mechanisms include reduction in insulin and sex steroid hormone levels. In addition to life-style modifications, the antidiabetic metformin may be proposed as preventive agent. Metformin reduces the metabolic syndrome, lowers insulin and testosterone levels in postmenopausal women, and it is a potent inhibitor of endometrial cancer cell proliferation.",
keywords = "Endometrial cancer, Endometrial hyperplasia, Insulin, Metformin, Sex hormones",
author = "Carlo Campagnoli and Chiara Abb{\`a} and Simona Ambroggio and Tiziana Brucato and Patrizia Pasanisi",
year = "2013",
month = "2",
doi = "10.3109/09513590.2012.706671",
language = "English",
volume = "29",
pages = "119--124",
journal = "Gynecological Endocrinology",
issn = "0951-3590",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Life-style and metformin for the prevention of endometrial pathology in postmenopausal women

AU - Campagnoli, Carlo

AU - Abbà, Chiara

AU - Ambroggio, Simona

AU - Brucato, Tiziana

AU - Pasanisi, Patrizia

PY - 2013/2

Y1 - 2013/2

N2 - In western women, the endometrium is frequently exposed, even after menopause, to the endogenous hormonal stimulation. Such a stimulation increases the risk of pathologic conditions such as endometrial hyperplasia and type I (endometrioid) endometrial adenocarcinoma. Metabolic syndrome, obesity, insulin resistance and type II diabetes promote the endometrial stimulation, and are recognized risk factors for endometrial cancer. Furthermore, chronic hyperinsulinemia linked both to obesity and metabolic syndrome influences endometrial proliferation through direct and indirect actions. Intentional weight loss, calorie restriction and physical activity are associated with a reduced risk of the endometrial pathology. Biological mechanisms include reduction in insulin and sex steroid hormone levels. In addition to life-style modifications, the antidiabetic metformin may be proposed as preventive agent. Metformin reduces the metabolic syndrome, lowers insulin and testosterone levels in postmenopausal women, and it is a potent inhibitor of endometrial cancer cell proliferation.

AB - In western women, the endometrium is frequently exposed, even after menopause, to the endogenous hormonal stimulation. Such a stimulation increases the risk of pathologic conditions such as endometrial hyperplasia and type I (endometrioid) endometrial adenocarcinoma. Metabolic syndrome, obesity, insulin resistance and type II diabetes promote the endometrial stimulation, and are recognized risk factors for endometrial cancer. Furthermore, chronic hyperinsulinemia linked both to obesity and metabolic syndrome influences endometrial proliferation through direct and indirect actions. Intentional weight loss, calorie restriction and physical activity are associated with a reduced risk of the endometrial pathology. Biological mechanisms include reduction in insulin and sex steroid hormone levels. In addition to life-style modifications, the antidiabetic metformin may be proposed as preventive agent. Metformin reduces the metabolic syndrome, lowers insulin and testosterone levels in postmenopausal women, and it is a potent inhibitor of endometrial cancer cell proliferation.

KW - Endometrial cancer

KW - Endometrial hyperplasia

KW - Insulin

KW - Metformin

KW - Sex hormones

UR - http://www.scopus.com/inward/record.url?scp=84871435086&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871435086&partnerID=8YFLogxK

U2 - 10.3109/09513590.2012.706671

DO - 10.3109/09513590.2012.706671

M3 - Article

C2 - 22946682

AN - SCOPUS:84871435086

VL - 29

SP - 119

EP - 124

JO - Gynecological Endocrinology

JF - Gynecological Endocrinology

SN - 0951-3590

IS - 2

ER -